From GlobeNewswire:

Generation Bio Co., a biotech company, has announced that its president and CEO, Geoff McDonough, M.D. will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2024. A live webcast and replay of the presentation will be available on the company’s website. Generation Bio aims to provide genetic medicines for people with rare and prevalent diseases. They use a non-viral genetic medicine platform designed to deliver durable, redosable treatments for specific tissues and cell types. They’ve developed RES, a high-scale manufacturing process to support their mission, extend the reach of genetic medicine, and produce hundreds of millions of doses. For more information, visit www.generationbio.com or contact Maren Killackey, Generation Bio, [email protected], 857-371-4638.



Read more: Generation Bio to Present at the 42nd Annual J.P. Morgan